Zoom: Analysts Anticipate $906 Million In Q1 Revenues

Zoom Video Communications (NASDAQ: ZM) will be reporting their first quarter financial results June 1st after market close. Analysts have a consensus $426.02 12-month price target on the company, via a total of 26 analysts, with seven analysts having strong buy ratings, five analysts having buy ratings, 13 have hold ratings and one analyst has a strong sell rating. The street high is an $550 price target from BTIG, and the lowest target sits at $250.

21 analysts have revenue estimates for the first quarter. The mean revenue estimate between all 21 analysts is $906.03 million; this number has been revised upwards from $838.30 million at the start of the year. The highest revenue estimate is $918.9 million, while the lowest is $738.38 million.

The analyst consensus for net income for the first quarter is $297.60 million, this is up from the start of the year at $232.18 million. The highest net income estimate is $314 million, while the lowest is $292 million.

Onto EBITDA estimates, there are currently only 7 analysts who have first quarter EBITDA estimates. The mean is currently $318.06 million, with this number having been revised higher from $256.32 million at the start of the year. The street high estimate currently sits at $332 million in EBITDA and the lowest is $305.34 million.

Analysts estimate that quarterly earnings per share will come in at $0.61, with this number being higher than the $0.44 estimate at the start of the year. The street high is $0.70 and the lowest estimate is $0.46 per share for the quarter.


Information for this briefing was found via Sedar and Refinitiv. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

This Gold Story Starts With Cash Flow | Gordon Robb – ESGold

Silverco Cusi Mine PEA: Bigger Isn’t Always Better

Fixing Heart Disease Tied to Sudden Death in Young People | David Elsley – Cardiol Therapeutics

Recommended

Silver47 Eyes Discovery in Nevada After Tripling Kennedy Project Footprint

BREAKING: Preliminary Magnitude 7.4 Earthquake Strikes Off Northern Japan, Tsunami Warning Issued

Related News

Canopy Growth: Canaccord Forecasts $119.2 Million In Q2 Net Revenues

This morning, Canaccord Genuity released their second-quarter earnings preview for Canopy Growth Corp (TSX: WEED)...

Friday, November 6, 2020, 02:58:00 PM

Eguana Tech: Stifel Reiterates Buy Rating Following Hawaii VPP Announcement

Last week, Eguana Technologies (TSXV: EGT) announced that they received their first order worth $3.6...

Sunday, July 11, 2021, 10:04:00 AM

Cresco Labs: Stifel Slashes Price Target From $30 To $8 Following Poor Q4 Results

On March 23rd, Cresco Labs (CSE: CL) announced its fourth-quarter financial results, which disappointed many...

Friday, March 25, 2022, 03:39:00 PM

Aphria: Canaccord Downgrades Company To Hold From Speculative Buy

Earlier this week, it was announced that Aphria Inc (TSX: APHA) (NASDAQ: APHA) and Tilray...

Friday, December 18, 2020, 12:05:00 PM

K92: BMO Anticipates Stage 3 Expansion To Come Earlier Than Expected

On October 7th, K92 Mining Inc. (TSX: KNT) announced that the board of directors has...

Friday, October 15, 2021, 04:33:00 PM